BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 10841073)

  • 1. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
    Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
    J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
    Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I; Krchnák V
    J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.
    Overall ML; Hertzog PJ
    Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
    Platis D; Foster GR
    J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
    Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
    J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human interferon omega--a review.
    Adolf GR
    Mult Scler; 1995; 1 Suppl 1():S44-7. PubMed ID: 9345398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
    Walter MR; Bordens R; Nagabhushan TL; Williams BR; Herberman RB; Dinarello CA; Borden EC; Trotta PP; Pestka S; Pfeffer LM
    Cancer Biother Radiopharm; 1998 Jun; 13(3):143-54. PubMed ID: 10850350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the basic three-dimensional structure of type I interferons and its functional and evolutionary implications.
    Mitsui Y; Senda T
    J Interferon Cytokine Res; 1997 Jun; 17(6):319-26. PubMed ID: 9197998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carboxyterminal domains of human IFN-alpha2 and IFN-alpha8 are antigenically homologous.
    Vancová I; Kontseková E; Mucha V; Kontsek P
    J Interferon Cytokine Res; 2000 May; 20(5):455-61. PubMed ID: 10841073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional models of interferon-alpha subtypes IFN-con1, IFN-alpha8, andIFN-alpha1 derived from the crystal structure of IFN-alpha2b.
    Walter MR
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-52-S9-62. PubMed ID: 9208873
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.